SARS-CoV-2 in hospital indoor environments is predominantly non-infectious

被引:9
作者
Krambrich, Janina [1 ]
Akaberi, Dario [1 ]
Ling, Jiaxin [1 ]
Hoffman, Tove [1 ]
Svensson, Lennart [2 ,3 ]
Hagbom, Marie [2 ]
Lundkvist, Ake [1 ]
机构
[1] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden
[2] Univ Linkoping, Med Fac, Dept Biomed & Clin Sci, Div Mol Med & Virol, Linkoping, Sweden
[3] Karolinska Inst, Dept Med Solna, Div Infect Dis, Stockholm, Sweden
基金
瑞典研究理事会;
关键词
SARS-CoV-2; COVID-19; RNase A; Environmental sampling; In vitro infection; Viral infectivity; VIRAL LOAD; CORONAVIRUS; SARS; STABILITY; VIRUS; PNEUMONIA; OUTBREAK;
D O I
10.1186/s12985-021-01556-6
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
BackgroundThe ongoing SARS-CoV-2 pandemic has spread rapidly worldwide and disease prevention is more important than ever. In the absence of a vaccine, knowledge of the transmission routes and risk areas of infection remain the most important existing tools to prevent further spread.MethodsHere we investigated the presence of the SARS-CoV-2 virus in the hospital environment at the Uppsala University Hospital Infectious Disease ward by RT-qPCR and determined the infectivity of the detected virus in vitro on Vero E6 cells.ResultsSARS-CoV-2 RNA was detected in several areas, although attempts to infect Vero E6 cells with positive samples were unsuccessful. However, RNase A treatment of positive samples prior to RNA extraction did not degrade viral RNA, indicating the presence of SARS-CoV-2 nucleocapsids or complete virus particles protecting the RNA as opposed to free viral RNA.ConclusionOur results show that even in places where a moderate concentration (Ct values between 30 and 38) of SARS-CoV-2 RNA was found; no infectious virus could be detected. This suggests that the SARS-CoV-2 virus in the hospital environment subsides in two states; as infectious and as non-infectious. Future work should investigate the reasons for the non-infectivity of SARS-CoV-2 virions.
引用
收藏
页数:9
相关论文
共 44 条
  • [1] Asymptomatic coronavirus infection: MERS-CoV and SARS-CoV-2 (COVID-19)
    Al-Tawfiq, Jaffar A.
    [J]. TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020, 35
  • [2] [Anonymous], 2020, REUTERS 1018
  • [3] Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility
    Arons, M. M.
    Hatfield, K. M.
    Reddy, S. C.
    Kimball, A.
    James, A.
    Jacobs, J. R.
    Taylor, J.
    Spicer, K.
    Bardossy, A. C.
    Oakley, L. P.
    Tanwar, S.
    Dyal, J. W.
    Harney, J.
    Chisty, Z.
    Bell, J. M.
    Methner, M.
    Paul, P.
    Carlson, C. M.
    McLaughlin, H. P.
    Thornburg, N.
    Tong, S.
    Tamin, A.
    Tao, Y.
    Uehara, A.
    Harcourt, J.
    Clark, S.
    Brostrom-Smith, C.
    Page, L. C.
    Kay, M.
    Lewis, J.
    Montgomery, P.
    Stone, N. D.
    Clark, T. A.
    Honein, M. A.
    Duchin, J. S.
    Jernigan, J. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (22) : 2081 - 2090
  • [4] Basu S., 2020, MEDRXIV
  • [5] Predicting Infectious Severe Acute Respiratory Syndrome Coronavirus 2 From Diagnostic Samples
    Bullard, Jared
    Dust, Kerry
    Funk, Duane
    Strong, James E.
    Alexander, David
    Garnett, Lauren
    Boodman, Carl
    Bello, Alexander
    Hedley, Adam
    Schiffman, Zachary
    Doan, Kaylie
    Bastien, Nathalie
    Li, Yan
    Van Caeseele, Paul G.
    Poliquin, Guillaume
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 71 (10) : 2663 - 2666
  • [6] CDC, 2020, PREPARATION VIRAL TR
  • [7] Centers for Disease Control and Prevention, 2020, DUR IS PREC AD COVID
  • [8] Chan K, 2011, ADV OPTOELECTRON, V2011, DOI [10.1155/2011/196707, 10.1155/2011/734690]
  • [9] Detection of SARS coronavirus in patients with suspected SARS
    Chan, KH
    Poon, LLLM
    Cheng, VCC
    Guan, Y
    Hung, IFN
    Kong, J
    Yam, LYC
    Seto, WH
    Yuen, KY
    Peiris, JSM
    [J]. EMERGING INFECTIOUS DISEASES, 2004, 10 (02) : 294 - 299
  • [10] Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI [10.1016/S2666-5247(20)30003-3, 10.1016/S2666-5247(20)30095-1]